BOULDER, Colo., June 2, 2022 /PRNewswire/ — Watchmaker Genomics, a life sciences company specializing in the development of high-stringency applications focused on the reading, writing, and editing of DNA and RNA, today announced it had secured $40 million in an oversubscribed Series A,…
Related Articles

News
Heidi Hendrix Joins the Sierra Space Executive Leadership Team as Chief People Officer
September 27, 2022
ucbiotech
News
Comments Off on Heidi Hendrix Joins the Sierra Space Executive Leadership Team as Chief People Officer
LOUISVILLE, Colo.–(BUSINESS WIRE)–Heidi Hendrix Joins the Sierra Space Executive Leadership Team as Chief People Officer Click here to view original post

News
‘Blue Brain Boost’: FDA blocks Colorado couple from importing and reselling drugs from China
January 20, 2023
ucbiotech
News
Comments Off on ‘Blue Brain Boost’: FDA blocks Colorado couple from importing and reselling drugs from China
A Colorado-based couple, Mark and Linda Godding, received a final debarment order from the FDA, stipulating that they cannot import drugs to the US for the next five years. The debarment comes as last summer […]

News
Weekly Policy Blog: Ethylene Oxide – Critical in Protecting Patient Health
August 26, 2022
ucbiotech
News
Comments Off on Weekly Policy Blog: Ethylene Oxide – Critical in Protecting Patient Health
Ethylene Oxide (EtO or EO) is a colorless gas used commercially in a wide variety of ways, including the production of textiles, personal care items, and the sterilization of medical devices, cosmetics, and spices. EtO […]